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ABSTRACT
A cross sectional study was conducted from November 2014 to April 2015 to determine the sero-
prevalence of brucellosis in selected sheep and goat product export abattoirs and to assess the
possible association of different epidemiological risk factors with the occurrence of the disease. A
total of 450 sera were collected from goats in those selected export abattoirs, using systematic
random sampling technique. Rose Bengal Plate Test was used as a screening test and detected
1.56% (N=7) of the samples as sero positive. Up on further testing by CFT for confirmation, only
1.11% (N=5) of the samples were positive. In this study there was no statistically significant
relationship observed between the risk factors like age, origin and sex (P>0.05), although higher
prevalence was observed in adults (1.97%), but statistically significant relationship was observed
between sero-prevalence and body condition of animals, where higher prevalence was observed in
poor body conditioned goats (p<0.05). In conclusion even though the overall prevalence observed
in this study was relatively low, the finding still has the capability to indicate the presence of the
disease and the importance of intervention in the areas from which the goats are supplied or
produced as there is risk of spread of the disease which is economically important. The existence of
the disease in those export abattoirs may lead to prohibition of export of slaughtered goats to Middle
East and other countries to preclude risk of zoonosis. This in turn results in loss of income from the
export sector. Therefore, awareness creation for animal owners and implementation of strategic
control measure is necessary to prevent further spread of the disease in the study area.
Keywords: Brucellosis, CFT, Ethiopia, Export abattoirs, Goats, RBPT, Zoonoses, cross sectional
study
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1. INTRODUCTION
Ethiopia is an agricultural based country and owns huge number of small ruminants, estimated to be
48.2 million head of sheep and goats (CSA, 2011). Of the total number of goats (about 21.7 million
head), 70% are found in low land pastoral areas. This is because they are well adapted to hot and dry
conditions and provide golden opportunity to alternatively exploit the potential of pastoral areas.
Goats are highly adapted to broad range of environmental conditions. Moreover, low cost of
production, requirement of little land and higher prolificacy made them attractive assets for
development. This makes investment in these animals avoid losses due to high inflation rates that
are found in unstable economies of many underdeveloped countries like Ethiopia. This is because
sheep and goats provide rapid cash turnover (Nigatu et al., 2014).
The small ruminants and their meat/milk products represent an important export commodity, which
significantly contribute to the national economy. Goats together with sheep contribute to a quarter of
the domestic meat consumption; about half of the domestic wool requirements; about 40% of fresh
skins and 92% of the value of semi- processed skin and hide export trade. It is estimated that
1,078,000 sheep and 1,128,000 goats are used in Ethiopia for domestic consumption annually. There
is also a growing export market for sheep and goats meat in the Middle Eastern Gulf states and some
African countries. At optimum off take rates, Ethiopia can export 700,000 sheep and 2 million goats
annually, and at the same time supply 1,078,000 sheep and 1,128,000 goats for the domestic market
(Alemu and Markel, 2008).
Even though this sector contributes much to the national economy, its development is hampered by
different constraints. The most important constraints to small ruminant production are poor
management system, low genetic endowment, and wide spread endemic diseases. Among many
factors that limit economic return from small ruminants, reproductive diseases including brucellosis
are the major disease constraints (ILRI, 2006).
Brucellosis is an infectious bacterial zoonotic disease caused by member of genus Brucella. The
disease is primary reproductive disease clinically characterized by abortion in the last trimester and
retained placenta in females whereas orchitis and epididymitis with frequent sterility in males
(Radostits and Inchcliff, 2000).
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The incidence of the disease in humans is thus closely tied to the prevalence of the infection in
sheep, goats and cattle, and practices that allow exposure of humans to potentially infected animals
or their products (Kaltungo et al., 2013).
Despite the presence of larger population of small ruminants in different regions of Ethiopia, very
limited researches are done on brucellosis, even if it is said to be endemic in the country. The sero-
prevalence of brucellosis in goat is variably reported in different parts of the country. Among this;
Prevalence of 4.8% from Afar region (Ashenafi et al., 2007), 1.3% from central highlands of
Ethiopia (Tekeleye and Kasali, 1990), 9.7% from Afar and Somali region (Teshale et al., 2007),
3.2% from Southern Ethiopia region (Mengistu et al., 2007), 2.12% in some export abattoirs were
reported (Nigatu et al., 2014). Occurrence of such disease might result in loss of income from
prohibition of export of live animals and their products due to its public health significance.
Therefore, it was found important to study brucellosis in goats purchased for slaughter in those
selected export abattoirs with the objective of:
Determining the sero-prevalence of brucellosis in goats in those selected export abattoirs
Assessing some of the possible epidemiological risk factors that might contribute for the
occurrence of brucellosis in goats.
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2. LITERATURE REVIEW
Brucellosis is an infectious bacterial disease caused by microorganisms of the genus Brucella and
affecting a number of animal species (yesuf et al., 2010).
2.1. Etiology
In goats brucellosis is mainly caused by Brucella melitensis, a gram negative, facultative
intracellular pathogen. B. melitensis contains three biovars (biovars 1, 2 and 3). All the three biovars
cause the disease in goats, but their geographic distribution varies. Brucella abortus and Brucella
suis infection also occur occasionally in goats, but clinical disease seems to be rare (CFSPH, 2009).
2.2 Culture, Morphology and Staining Characteristics
Brucella members are aerobic, but some strains require 5-10% carbon dioxide (CO2) added for
growth, especially on primary isolation. The optimum pH for growth varies from 6.6 to 7.4 and
culture media should be adequately buffered near pH 6.8 for optimum growth. The optimum growth
temperature is 36-38°C, but most strains can grow between 20°C and 40°C. Brucella requires biotin,
thiamin and nicotinamide. The growth of most Brucella strains is inhibited on media containing bile
salts, tellurite or selenite (European commission, 2001).
Brucella will appear as punctuate colonies after 48 h of incubation. Colonies are non pigmented and
non hemolytic. They have a characteristic Gram stain morphology that is extremely helpful in
differentiating them from other gram negative organisms. Brucella cells appear as tiny, faintly
stained cocco-bacilli (CDC, 2001)
Brucella species may also appear as short rods, 0.6 – 1.5 µm long by 0.5 – 0.7 µm width. They are
arranged singly and less frequently in pairs, short chains or small groups. It doesn’t possess capsule,
spore and flagella. Brucella spp. are Gram-negative and usually do not show bipolar staining. They
are not truly acid-fast but resist decoloration by weak acids, thus stain red by the Stamp's
modification of Ziehl-Neelsen method (European commission, 2001).
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2.3 Epidemiology
Brucellosis is one of the most wide spread zoonotic disease globally. Brucella spp. are capable of
causing disease in a variety of animal species, including humans (Garrity et al., 2001).
Table 1. Zoonotic potential and host preferences of Brucella species
Species Zoonotic potential Host preference
Brucella melitensis High Goat, Sheep
Brucella abortus Moderate Cattle
Brucella suis Moderate Pig
Brucella canis Mild Dog
Brucella ovis Absent Sheep
Brucella neotomae Absent Desert wood rat
(Neotomae lepidae)
Brucella ceti Mild Cetaceans
Brucella pinnipedialis Mild Seals
Brucella microti Absent Common voles
(microtus arvalis)
Source: Xavier et al (2010)
Brucella melitensis is the most virulent species of Brucella genus and has three biovars, with biovar
1 and 3 being the ones isolated frequently in small ruminants in the Mediterranean, the Middle East
and Latin America (Benkirane, 2006).
Goats are the classic and natural hosts of B.melitensis and, together with sheep, are its preferred
host. In pathological and epidemiological terms, B.melitensis infection in goats is similar to
B.abortus infection in cattle (Aparicio, 2013).
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2.3.1 Geographical Distribution
Of the three different biovars of B.melitensis biovar 3 predominates almost exclusively in
Mediterranean countries and Middle East, while biovar 1 seems to predominate in Latin America.
The biovars 1 and 2 have also been reported in some southern European countries. In the European
Union the following Member States and regions have been recognized as being free from
B.melitensis: Belgium, Denmark, Finland, Germany, Ireland, Luxembourg, the Netherlands,
Sweden, the United Kingdom, 17 Departments of France and 2 Provinces of Spain (European
commission, 2001).
Distribution of B. melitenesis in some countries of Africa is indicated in the following table.
Table 2. Distribution of B.melitenesis in some countries of Africa.
Country B.melitenesis
Egypt +
Ethiopia +
Kenya +
Sudan +
Somalia +
Eritrea +
Libya ND
Algeria +
Tunisia ND
Niger ++
CoteD’ivory +
Zimbabwe -
Botswana +
Nigeria -
South Africa +
Remark: ++ = high prevalence, + = sporadic low prevalence, ND = no data
Source: FAO, (2003).
Ethiopia
There is paucity of data on the status of data on small ruminant brucellosis in Ethiopia. The
following table shows the reports of different research on brucellosis in goats in different parts of
Ethiopia.
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Table 3. Prevalence of goat brucellosis in Ethiopia
Reporters Reported prevalence Areas of Reports
Tekelye and Kasali (1990) 1.3% Central highlands
Yibeltal (2005) 16% Afar region
Teshale et al. (2006) 1.7% Somali region
Ashenafi et al. (2007) 5.8% Pastoral region of Afar
Mengistu (2007) 2.0% Southern Ethiopia
Bekele (2011) 2.0% Jijiga
Nigatu et al. (2011) 2.12% Selected export abattoirs
Dabassa et al. (2013) 1.88% Yabello district
Tsehay et al. (2014) 3.09% pastoral areas of Somali and
Oromia region
2.3.2 Age and Sex
B.melitensis infection causes disease only in adult (sexually mature) animals. Young animals may be
infected but do not show any clinical sign and generally show only a weak and transient serological
response. However, susceptibility increases after sexual maturity and especially with pregnancy
(European commission, 2001). In B. melitenesis infection, male goats are less susceptible than
females (FAO, 2003). According to the study of Ashenafi et al. (2007), prevalence rate of 5.3% was
observed in adult and 1.6% in younger goats. While Nigatu et al. (2014) and Tsehay et al. (2014)
observed no statistically significant difference in susceptibility between various age groups.
2.3.3 Breed
Exotic breeds and their hybrids are found to be at higher risk; this may be associated with their
better productivity and intensive management (Garrido et al., 2001).
2.3.4 Transmission
The main route of infection is via suckling or licking of aborted fetus and their placentas as well as
vaginal discharges. The infection may also be transmitted from goats to kids—a small percentage in
utero, but the majority via the ingestion of infected milk or colostrums. These kids greatly increase
the difficulty of eradicating B.melitensis from the herd or flock as the infection may persist until
adulthood in these kids without the induction of detectable antibodies (Coetzer and Tustin, 2004).
The organism can survive on pasture for several months but transmission by fomites is believed to
have no practical significance (Radostitis et al., 2007).
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2.4 Pathogenesis
The mucosal surface of the alimentary tract is the principal route of entry for B. melitensis (Carlos et
al., 2011). Unlike many other pathogens, Brucella spp. invade host cells without activating innate
immune defence systems and then resist intracellular killing to persist in the host (Gorvel and
Moreno, 2002; Barquero et al., 2007).
The major virulence mechanisms of Brucella already identified are those required for host cell
invasion and intracellular survival or replication (Arellano, 2005).
Brucella spp. are capable of invading and surviving in both phagocytic and non phagocytic host
cells (Celli, 2006). Macrophages, dendritic cells (DCs), and trophoblasts represent the major target
cells for Brucella. In order to reach its target cells, Brucella needs to cross mucosal barriers of
respiratory, genitourinary or digestive tract, where it undergoes phagocytosis by resisdent
macrophages and DCs, resulting in dissemination of the organism to lymphoid and reproductive
organs (Xavier, 2010).
Once ingested, some of Brucella organisms are able to evade or hinder the phagolysosomal action of
the neutrophils and macrophages by redirecting the intracellular trafficking of phagolysosomal
action (Dornand et al., 2002; Gorvel and Moreno, 2002; Franco et al., 2007). The virulence factor
VirB, is a secretory pump that selectively pumps proteins and macromolecules and is critical in the
pathogenesis and virulence of Brucellosis infection (Franco et al., 2007).
The persistence of the bacteria in the phagocytic cells allows for bacterial replication in these cells.
Replication leads to release of the bacteria from the cells, thus resulting in bacteremic phase. This
bacteremia allows for colonization of the bacteria in multiple tissues, but in livestock the bacteria
most frequently colonize in the lymphoid tissues, mammary gland and reproductive tract (Ragan,
2002).
The localization of Brucella spp. in reproductive tract leads to colonization of the chorionic
trophoblast of the placenta in pregnant livestock (Corbel, 2006). The resulting placentitis caused by
replicating bacteria results in ulceration of the chorioallantoic membrane while sparing the
endometrium of uterus. The resulting pathology leads to late gestation abortions in naively infected
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livestock (Radostits et al., 2010). The presence of erythritol in the testes of male species leads to
colonization of Brucella spp. in their reproductive tracts with a resulting epididymitis and orchitis
(Enright, 1990).
2.5 Clinical Signs
According to Coetzer and Tustin (2004) clinical signs associated with B. melitensis infection in
goats include: abortion storm in susceptible herd usually in late gestation, kids from infected females
may be born weak or asymptomatic, retention of placenta and fetal membranes especially in nany
goats, copious genital secretions which may persist for up to 3 months following abortion, decreased
milk yield as well as quality, orchitis or epididymitis and hygroma.
2.6 Diagnostic Methods
Diagnostic tests can be applied with different goals: confirmatory diagnosis, screening or prevalence
studies, certification, and in countries where brucellosis is eradicated, surveillance in order to avoid
re introduction of the disease through importation of infected animals or animal products. these
methods include direct tests, involving microbiological analysis or DNA detection by polymerase
chain reaction (PCR)-based methods and indirect tests, which are applied either in vitro (mainly to
milk and blood) or in vivo (allergic tests) (Godfroid et al., 2010).
The most widely used serum-testing procedures for the diagnosis of Brucella infections in goats are
the buffered Brucella antigen tests (BBAT), and the complement fixation test (CFT) which are
considered by the OIE also as “ prescribed tests for trade” (OIE, 2009).
The World Organization for Animal Health (OIE) prescribes the use of a buffered Brucella antigen
test called the buffered plate antigen test and the Rose Bengal Test (RBT) as approved screening
tests and the complement fixation test as the confirmatory test (Havas, 2011).
2.7 Treatment
Treatment is unlikely to be undertaken in animals and is also unlikely to be economically or
therapeutically effective. A cure rate of 65% and 100% respectively was reported intra peritoneal
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administration of 500mg and1000mg of tetracycline to naturally infected goats for a period of 6
weeks. A dose of 100mg of long acting tetracycline given every 3 days for a period 6 weeks
achieved a cure rate of 75% (Radostitis et al., 2007).
2.8. Control and Prevention
Reducing brucellosis zoonosis requires reducing the exposure of humans to the disease agent. There
are two primary exposure patterns of importance that can be targeted for intervention. The first is
occupational-associated exposure. The second route of exposure is through contaminated food such
as fresh and soft cheese made from raw milk, and other dairy products made from raw milk with a
high water content, low salinity, and low curing time in high salinity and a pH > 5 (Corbel, 2006).
Occupational disease is controlled through the animal population. There is no human vaccine
available to directly protect the workers (Shurig et al., 2002), but there are effective B. melitensis
vaccines for small ruminants (Radostits et al., 2007). The small ruminant B. melitensis vaccine is the
Rev 1 modified live vaccine; hence, vaccination in pregnant animals cause abortion, interfere with
serologic tests, complicating disease control and eradication programs (Havas et al., 2011).
Mass vaccination of livestock together with other measures such as movement control and testing
and isolation of infected animals, can effectively control brucellosis in the animal population and
eventually reduce the transmission to the human population (Smits and Kadri, 2005).
Direct food safety techniques can be applied to dairy products. From all meats, except those
contaminated with B. suis, the risk of infection via consumption is rare (ICMSF, 1996). The
majority of risk comes from the contamination of dairy products. Brucella spp. are readily killed by
pasteurization or heating of raw milk (Havas et al., 2011).
According to Yohannes et al., (2013), in areas where the disease is less prevalent (for example,
livestock sero-prevalence of less than 1%), it is recommended to practice test and cull policy with
compensation. For areas with high and moderate prevalence (>5%) under well-organized farming
systems, it is recommended to practice test and segregation policy by which animals with brucellosis
will be isolated and products consumed after pasteurization, with animals being disposed properly at
the end of their productive live.
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There are many component parts to eradicate the disease i.e. test and slaughter, continued
vaccination of replacement stock, animal movement control, availability of disease-free
replacements of the slaughtered animals and an adequate surveillance system (Corbel, 2006).
2.9 Public Health Aspect
Brucellosis is one of the world’s major zoonoses, that still is of veterinarian, public health and
economic concern in many parts of the world (Smits and Kadri 2005). Brucellosis was first
recognized as a disease affecting humans on the Island of Malta in the early 20th century. Though its
distribution is worldwide; yet brucellosis is more common in countries with poorly standardized
animal and public health program (Capasso, 2002).
Animals are the only significant source of human brucellosis, and transmission is via direct contact
(e.g. veterinarians, abattoir workers, lab workers, and livestock keepers) and through consumption
of unpasteurised dairy products. Human brucellosis is a grave and debilitating disease that may lead
to permanent sequelae, requires prolonged and combined antibiotherapy, and is fatal in 1%–5% of
untreated cases (Ducrotoy et al., 2014). In humans, brucellosis can be caused by B.abortus,
B.melitensis, B.suis biovar 1-4 and, rarely, B.canis or marine mammal Brucella, but B.ovis, B.
neotomae, and B.suis biovar 5 have not been associated with human disease (Lopes et al., 2010). Of
this, B.melitensis is highly pathogenic and considered to be the most sever human pathogen in the
genus (CFSPH, 2009).
Humans are incidental host of brucellosis, and the pathogenesis from initial infection to phagocytic
cell uptake is identical to animal hosts. The lysis of phagocytic cells that releases the Brucella
organisms also results in release of cellular debris and pyrogenic endotoxins that cause an episode of
fever when this occurred repeatedly in different infected phagocytic cells, so can the fever-undulant
fever (Havas et al., 2011). After an incubation period of 8 to 20 days symptoms include lassitude,
headache and muscular or joint pain, and drenching sweats, especially at night (European
commission, 2001).
The epidemiology of human brucellosis has drastically changed over the past few years because of
various sanitary socio-economic and politic reasons, together with increased international travel.
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New foci of brucellosis have emerged, particularly in central Asia, while the situation in certain
countries of the Middle East is rapidly worsening. The disease occurred worldwide except in those
countries where animal brucellosis has been eradicated (Pappas et al., 2006b).
As compared to animal brucellosis, study of human brucellosis in Ethiopia is sparse. For instance
out of 56 cases with fever of unknown origin, two (3.6%) were reported to be positive for B.abortus
antibody by RBPT and CFT (Tolosa et al., 2007).
A study conducted in traditional pastoral communities by Ragassa et al. (2009) using B.abortus
antigen revealed that 34.1% patients with febrile illness from Borena, 29.4% patients from Hamer
and 3 % patients from metema areas were tested positive. Studies conducted in high risk group such
as farmers, veterinary professional, meat inspectors and artificial insemination technicians in
Amhara regional state (Mussie et al., 2007b), sidama zone of Southern nations and nationalities state
(Kassahun et al., 2007) and Addis Ababa (Kassahun et al., 2006) found a sero-prevalence of 5.3%,
3.78% and 4.8% by screening sera from 238, 38 and 336 individuals respectively. The discrepancy
between Ragassa et al. (2009) and others might be due to difference in milk consumption habits and
sensitivity of the test methods used.
2.10 Economic Importance
Brucellosis is consistently ranked among the most economically important zoonoses globally (Perry
and Grace, 2009). In low income countries, brucellosis is endemic and neglected, with large disease
and livelihood burdens in animals and people and almost no effective control (McDermott and
Arimi, 2002). The economic losses stem from reduction in meat yield, abortion, still birth, repeat
breeding, banning of export of live animals and their products and infertility problems (Radostits, et
al., 2010).
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Table 4: Costs to be considered and estimated in planning brucellosis control and eradication
programs
Actors Cost of illness Cost of prevention
Private Individuals and households Treatment, loss of house hold
production
Risk mitigation such as
boiling milk
Livestock sectors Treatment, herd slaughter,
market loss due to risk of
infected meat & milk, mortality,
morbidity, lower production,
loss of exports
Increased biosecurity,
vaccination and
procedures to control
disease along the value
chain ( pasteurization)
Public Health sector (human and
animal)
Treatment(hospital provision,
etc), outbreak costs, movement
restrictions, culling, vaccination
Risk mitigation such as
movement control and
vaccination, disease
surveillance research
Economy Indirect effects on economic
development, ecosystem
services and tourism
Biosecurity, avoiding
wild life and vectors,
disease surveillance,
research
Source: McDermott et al. (2013).
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3. MATERIALS AND METHODS
3.1 Study Area and Abattoirs
The study was conducted in some selected export abattoirs found in Debre-Zeit and Modjo town.
Debre-Zeit is located between latitude of 8o 45ʹ N and longitude of 38o 59ʹ E and it is 47.9 km South
East of Addis Ababa, the capital city of Ethiopia, While Modjo town is the center of Lume district in
Eastern Shewa Administrative Zone of Oromia Regional State. It is located 70 kilometers south east
of Addis Ababa 8oN and 39oE at an altitude of 1777 meter above sea level (CSA, 2013).
The animals were supplied from different parts of the country. For most of the areas the average
annual rainfall range from 400 to700 mm and with the mean daily temperature is 25-44oC, while for
few others rain fall pattern can be characterized as erratic, unreliable and unpredictable with average
rain fall of 200 mm. average daily temperature of  28-44oC (CSA, 2011).
The slaughtering capacity of these export abattoirs range from 800 up to 1500 goats per day on
average and they export mutton, goat meat and edible organs like liver, kidney and heart to the
Middle East countries.
3.2 Study Population
About 450 sera were collected from goats that were purchased for slaughter. All the study animals
were male and unvaccinated against Brucella. The origins of the animals were different areas in the
country. The animals were purchased from farmers on weight basis and certain weight ranges were
approved depending on the customers’ preferences. Mostly those goats weighting 10-12kg were
rejected. The study animals were with different age category mainly within a range of 1-4 years.
Their age was determined based on their dental eruption patterns. In general according to Steel
(1996) goats were classified as young and adult i.e., young if 1-3 years old and having up to four
permanent teeth and adult if 4-5 years and greater than four permanent teeth (Annex-1and 5).
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3.3 Sampling Method and Sample Size
The sampling method employed was systematic random sampling by choosing the first case and the
interval between cases with lottery method. The sample size was determined according to Thrusfield
(2005) as indicated below. Previous study conducted by Nigatu et al., (2014) on the prevalence of
brucellosis in goats in the same area showed 2.12%. Therefore, using 2.12% as expected prevalence
and 5% absolute precision at 95% confidence level, the number of animals needed in the study was
32. However, to increase the level of precision of the prevalence, the sample size was increased to
more than 10 folds i.e. 450.
n = 1.962 Pexp (1-Pexp) where: n = sample size
d2 Pexp = expected prevalence
d = desired absolute precision
3.4. Data Recording
While collecting the blood specimens from study animals, we recorded the data corresponding to
each animal such as origin, body condition, species, sex, and age in pre designed recording sheet
(Annex-2).
3.5 Blood Sample Collection
About 10ml of blood was collected from the jugular vein of each goat using sterile plain vacutainer
tubes and needles. Each sample was labeled using codes describing the specific animal. Blood was
allowed to clot for 1-2 hours at room temperature, stored in slant position overnight at 4oC then
serum was separated from clotted blood. Separated serum was collected in a screw caped sterilized
plastic vial and was stored at -20 oC until tested.
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3.6. Laboratory techniques
3.6.1 Rose Bengal Plate Test (RBPT)
Rose Bengal Plate Test (RBPT) was used as a screening test for presence of Brucella antibody in the
serum samples collected. According to the procedure described by OIE, (2009) the antigen used was
Rose Bengal antigen, which constitutes a suspension of B. abortus inactivated by heat and phenol
dispensed in an acidified buffered and stained by Rose Bengal. The test was carried out at the
National Animal Health Diagnostic and Investigation Center (NAHDIC), Sebeta, Ethiopia which is
certified for ISO/IEC 1705/25 (Annnex-3).
3.6.2 Complement Fixation Test (CFT)
All the RBPT positive sera were re-tested using CFT (also carried out at NAHDIC) for further
confirmation according to the protocol described in OIE manual (2009). Standard B. abortus antigen
(0.2 CH 63) which was supplied from AHVLA was used for CFT to confirm the presence of anti-
Brucella antibodies in the sera (Annex- 4).
3.7. Data Management and Analysis
Data collected from abattoirs and obtained in laboratory were entered into a computer, on Microsoft
Excel spread sheet. Statistical analysis (descriptive analysis) was performed using ‘Statistical
Package for the Social Sciences’ (SPSS) version 16. The degree of association between each risk
factor was assessed using the Chi-square (x²) test. For all analyses, a p-value of less than 0.05 was
taken as significant.
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4. RESULTS
A total of 450 sera were tested for the presence of serum antibodies against Brucella infection in
goats in those selected export abattoirs. Seven sera were found positive up on RBPT; up on re-
testing of these samples for confirmation using CFT, only five sera were found to be positive.
Table 5: Sero -prevalence of brucellosis in goats in relation to Abattoirs in selected export abattoirs,
Ethiopia
Abattoirs Number of RBPT CFT
Samples tested
Negative          Positive Negative         Positive
Abt-1 50 49 1(2%) 49 1(2%)
Abt-2 50 50 0(0%) 50 0(0%)
Abt-3 100 98 2(2%) 99 1(1%)
Abt-4 150 147 3(2%) 148 2(1.3%)
Abt-5 100 99 1(1%) 99 1(1%)
Total 450 443(98.4%) 7(1.56%) 445(98.9%) 5(1.1%)
χ2 (4) =1.379, P=0.848 χ2 (4) = 1.011, P=0.908
Remark: - “Abt 1-5”= code for abattoir 1 to 5
Sero-prevalence of 2% (1 out of 50), 0% (0 out of 50), 1% (1 out of 100), 1.3% (2 out of 150), and
1% (1 out of 100) was recorded in Abattoir 1, 2, 3, 4, and 5 respectively. The difference was not
statistically significant (p>0.05) (Table-4).
Sero-prevalence of 0.4% (1 out of 247) and 1.97% (4 out of 203) was observed in young and adult
goats, respectively and the difference in prevalence was not statistically significant (Table 5).
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Table 6: Sero -prevalence of Brucellosis in goats in relation to Age in selected export abattoirs,
Ethiopia
Age category            Number of animals RBPT                        CFT positive
Negative         Positive      Negative Positive
Young 247 245 2(0.8%)       246 1(0.4%)
Adult 203 198 5(2.46%)       199 4(1.97%)
Total 450 443 7(1.56%) 445         5(1.11%)
χ2 (1) = 1.989, P=0.158                             χ2 (1) = 2.486, P =0.115
OR (adult) = 3.093 OR(adult) = 4.945
Table 7: Sero-prevalence of brucellosis in goats in relation to body condition in selected Export
abattoirs, Ethiopia
Body condition Number of animals RBPT CFT
Negative Positive      Negative Positive
Poor 31 25 6(19.35%) 26 5(16.1%)
Medium 118 117 1(0.8%) 118 0 (0%)
Good 301 301 0(0%) 301 0 (0%)
Total 450 443 7(1.56%) 445 5(1.11%)
χ2 (2) = 69.27, P = 0.00 χ2 (2) = 68.34, P = 0.00
Sero- prevalence of 16.1% (5 out of 31), 0% (0 of 118) and 0% (0 out of 301) were observed, in
poor, medium, and good body conditioned goats respectively. The difference in prevalence is
statistically highly significant (p<0.05) (Table 6).
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Table 8: Sero-prevalence of brucellosis in relation to origin of animal in selected export abattoirs,
Ethiopia
Origin Number of animals RBPT CFT
Negative Positive Negative Positive
Boran 122 119 3(2.45%) 120 2(1.63%)
Arbaminch 104 101 3(2.88%) 101 3(2.88%)
Somali 111 110 1(0.90%) 111 0 (0%)
Harar 113 113 0(0%) 113 0 (0%)
Total 450 447 7(1.56%) 445 5(1.1%)
χ2 (3) = 3.94, P = 0.267 x2 (3) =5.804, P=0.122
Sero-prevalence of 1.63% (2 out of 122), 2.9% (3 out of 104), 0% (0 out of 111), and 0% (0 out of
113) were recorded in Boran, Arbaminch, Somali, and Harar respectively. The difference in
prevalence was not statistically significant (p > 0.05) (Table 7).
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5. DISCUSSION
The present study indicated that, the overall sero-prevalence of brucellosis in goats in those selected
export abattoirs to be 1.56% (N=7) with RBPT and 1.11% (N=5) with CFT. Two of the samples
tested positive for brucella antibodies by RBPT, tested negative by CFT. This could be due to cross-
reactions between Brucella and other bacteria which share similar epitopes, which might result in
false positive result.
A 1.11% CFT confirmed finding of this study was in line with previous studies conducted by
Tekelye and Kasali (1990), who reported a sero-prevalence of 1.3% in goats from central highlands,
Bamaiyi et al., (2015), who reported sero-prevalence of 0.91% in goats from Malaysia, and Ferede
et al., (2011) who reported a sero-prevalence of 0.87% in goat from Bahir Dar.
The sero-prevalence of Brucellosis in goats in this study was lower than most of the sero-prevalence
reported by different previous studies i.e. lower than studies by: Yibeltal (2005), who documented a
prevalence of 16% in Afar region, Mengistu et al. (2007) who reported 3.2 % prevalence in goats in
southern Ethiopia, Ashenafi et al. (2007) who reported a sero-prevalence of 5.8% in goats of
pastoral regions of Afar, Bekele (2011) who reported 2 % sero-prevalence in goats in Jijiga, Dabassa
et al. (2013) who documented 1.88 % in goats in Yabello district, and Nigatu et al. (2014) who
reported 2.12 % sero-prevalence, and Tsehay et al. (2014) who reported 3.09 % sero-prevalence in
goats of pastoral areas of Somali and Oromia region.
The difference in the sero-prevalence of brucellosis between the current and previous studies might
be due to difference in geographical location of sampled animals since abattoirs purchased both
from highlands and lowlands of various regions, sample size, and/or the test protocols used in the
study.
A 1.11 % CFT confirmed prevalence of this study appeared generally to be low when compared
with most previous studies involving both female and male animals. This might be because of
infected male animals are usually observed to be non reactors to serological tests due to low
antibody titer (Crawford et al., 1990), and because serological tests under estimate brucellosis in
males due to the colonization of the bacteria in the testes and reticulo-endothelial system (Lapriak,
1982).
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Since all study animals were caprine, male (due to unslaughter of female animals in those export
abattoirs) and local breeds, no statistics had been computed on species, sex and breed. However,
comparison of sero-prevalence of caprine brucellosis was carried out for different epidemiological
risk factors like origin, age and body condition of goats. Accordingly, there were no statistically
significant variations observed between brucellosis sero-prevalence and origin of the animals
(P>0.05). This might be due to similarity of the geographical nature of the areas from which the
animals were sourced and sampled.
However prevalence rate varied significantly (p < 0.05) with body conditions in which higher
prevalence was observed in poor body conditioned goats than that of medium and good body
conditioned ones. This variation may be due to the possible associations of higher prevalence of
brucellosis occurrence in the presence of various infectious diseases that can lead to the reduction of
body weight, such as tuberculosis (Gorsich, 2012).
The prevalence of goat brucellosis in young animals in this study was 0.40% (1 out of 247), while
that of adults was 1.97% (4 out of 203). In fact B.melitensis causes disease only in adult (sexually
mature) females and males. Young animals may be infected but do not show any clinical sign and
generally show only a weak and transient serological response (European Commission, 2001).
Statistical analysis of the data showed that there was no significant difference in sero-prevalence of
Brucella antibodies between age groups, though older age group showed relatively higher
prevalence. This finding was in agreement with previous reports of Tsehay et al. (2014) and Nigatu
et al. (2014) who did not observe statistically significant difference between the sero-prevalence of
brucellosis and age. Ashenafi et al. (2007) also reported a higher prevalence of brucellosis in adult
goats in pastoral region of Afar, than younger ones which was in agreement with this study,
however statistically significant relation was recorded between sero prevalence of brucellosis and
age category (p<0.05). This difference might be due to variations in sample size and sample
collection areas.
.
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6. CONCLUSION AND RECOMMENDATIONS
Brucellosis is one of the “neglected diseases of poverty” which is endemic zoonotic disease that is
found primarily in impoverished parts of the world that are heavily reliant on livestock agriculture
(World Health Organization, 2006; Blasco and Molina-Flores, 2011).
The sero prevalence study carried out in this study and the studies conducted so far in Ethiopia
indicated that, Brucellosis might be one of the important diseases in goat raising districts.
In the present study, relatively low number of sero-reactors was identified in those export abattoirs.
Even though no statically significant difference were recorded in the prevalence rates between the
categories of each risk factors tested, there was a statistically highly significant difference on the
prevalence rate of brucellosis among different categories of body conditions, where the disease was
highly prevalent in poor conditioned goats than medium and good conditioned ones.
Though the causative agent, Brucella is not resistant to mild unfavorable environmental conditions
and may die at lower pH of meat, positive sero-reactors existence in those animals subjected for
slaughter may lead to ban of export of meat and meat-products to avoid zoonotic risks. Therefore it
is strongly recommended to perform screening tests in goats that are supplied to abattoirs before
slaughtering process, improve awareness of animal owners about the risk of brucellosis and its mode
of transmission to control the dissemination of the disease.
Therefore based on the above conclusion the following recommendations are forwarded:
 Brucellosis positive animals can be potential hazard to susceptible animals and public health;
therefore, screening test should be practiced before selection of animals for slaughter.
 Further and detail epidemiological study should be undertaken in those areas that supply
livestock for export abattoirs to know the level and the trend of the disease dynamics, and to
estimate the economic significance of the disease
 Even though the prevalence reported in this study was low, it can be potential hazard for
public health in the study area; therefore, the public especially small ruminant producers
should be aware of the risk of brucellosis.
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 For both human and animal brucellosis, extension services should include emphasis
on addressing the impacts of risk factors for the occurrence of brucellosis. Furthermore,
interdisciplinary collaboration and joint ventures among health and related professionals is of
paramount importance to control this disease that currently perpetuates poverty.
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8. ANNEXES
Annex 1: Estimation of Age of Goats
Number of Permanent teeth Estimated age range of goats
None Less than 1 years
1 pair 1 -2 years
2 pair 2-3 years
3 pair 3-4 year
4 pair More than 4 year
Broken Aged
Source: Desta (2009).
Annex 2: Data Collection Sheet
Date ……………………………....
Region ……………………………
Zone ………………………………
District ……………………………
Name of abattoir ………………….
Case
No.
Risk factors
Origin Species Sex Age Body condition
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Annex 3: Rose Bengal Plate Test (RBPT)
a. Materials
- White Porcelain Plate
- Micropipette of 75µl and 25 µl
- Micropipette tips
- Applicator sticks
b. Reagents
- RBPT Brucella antigen
- Positive control serum
- Negative control serum/ from previously tested negative serum/
- Test sera
c. Test Procedure
- The antigen, control and test sera were removed from the refrigerator and kept at room
temperature for 30 minutes before the test commenced.
- White porcelain and glass plates with twelve shallow wells
- Then 75µl of sera were dispensed into each well using micro pipette in a direction from
left to right as it was labeled on the plate ( except well ‘3’ and well ‘4’ of raw ‘3’ of the
plate, which were dispensed with positive and negative control sera respectively, all
other wells were dispensed with test sera).
- After the sera has been distributed, the antigen bottle was shaken then 25µl antigen was
dispensed along side of each serum
- Then the antigen and the sera were mixed using applicator stick
- Timer was set  for 4 min and plate was rocked manually backward and forward until 4
minutes elapsed
- After testing and reading the results plates were sent to washing and sterilization room
where they were sterilized and wrapped in aluminum foils and made ready for re-use.
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d. Interpretation of results
- After four minutes of rocking, any visible agglutination was considered as positive
(OIE, 2009).
- Agglutination was recorded as 0, +, ++, and +++
- According to the degree of agglutination, a score of ‘0’ indicates the absence of
agglutination, ‘+’ indicates barely perceptible agglutinations, ‘++’ indicates fine
agglutination, and ‘+++’ indicates clear clumping
- Those samples with no agglutination, ‘0’ were recorded as negative while those with
‘+’, ‘++’, and ‘+++’ were recorded as positive
Annex 4: Complement Fixation Test
A. Reagents
- Complement
- Hemolytic serum (Amboceptor)
- Hemolytic system
- Brucella antigen
- Sheep Red Blood Cells (sRBC)
- Brucella abortus positive control serum
- Negative reference serum
- CFT buffer
- Alsever’s solution
B. Materials
- 96 well U bottomed micro plate
- Mono-channel, Multi-channel micropipette which enable to dispense 25µl
- Water bath (NICKEL ELECTRO)
- Incubator shaker + 37oC (INSL-England)
- Bench to centrifuge (SIGMA 4-10)
- Trough
- PH meter
- Syringe
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- Sheet or plate lay out for records
- Shaker (R 100 rotates shaker)
- View box
C. Titration of the complement
1. First a 1/40 dilution of the complement in Veronal Calcium Magnesium (VCM)
buffer was prepared. Then the following dilution in micro plates; all volumes were
expressed in µl
2. Then the micro plates were dispensed in the quantities and orders shown in the table
below
Well  no 1 2 3 4 5 6 7 8 9
1/40
complement
10 15 20 25 30 35 40 45 50
VCM 40 35 30 25 20 15 10 5 0
Antigen 25 25 25 25 25 25 25 25 25
3. The mixture was homogenized by flipping the plates gently and put it at 37 oC for 30
minutes the we added
Hemolytic
system
25 25 25 25 25 25 25 25 25
4. The micro plate was incubated in incubator shaker at 37oC for 30 minutes, then took
out the micro plate well and centrifuged for 5 minutes at 2500 rpm.
5. The micro plate was removed from the centrifuge and the result was read. The quantity
of complement in the first well to show complete hemolysis was unit 1 and the
quantity in the next well was 2 units and used in the diagnostic test.
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For example, if hemolysis is absent or incomplete in wells 1-4, 10 µl -25 µl and
complete in wells 5 to 9, i.e. 30 µl-50 µl in this case 30 µl is 1 unit and 35 µl will be
taken for diagnostic test which represent 2 units. Calculation takes the ratio of
complement volume in the final dilution which 35 µl/100 µl= 0.35, using the formula
40/4×0.35=28. Then the dilution of the complement will be made 1/28 as indicated in
the table below
Well
dilution
1/100 1/66 1/50 1/40 1/33 1/28 1/25 1/22 1/20
D. Preparation of 3% sheep red blood suspension
- Blood was collected from Brucella antibody negative ( upon CFT ) sheep
- Blood was collected at a ratio of 50% blood to 50% Alsever’s solution, mixed thoroughly
by gentle rotation of the container
- Date of collection was recorded
- After collection, it was stored at +4oC and 72 hours after collection it was ready for use
E. Hemolytic system
- It was prepared by mixing the Amboceptor working dilution 1:1 with the 3 % erythrocyte
suspension then homogenized using R100 Rota test shaker for 30 minutes
F. Test Procedure
- Test sera, including positive and negative controls were Decomplemented in hot water
bath at 58 oC for 30 minutes
- A U-shaped 96 microtiter plate wells was Prepared
- The test sera was diluted 1:2 ( 100 µl test serum in 100 µl VCM )
- We used column 1 through 12 for test samples
- We used each well of row ‘A’ for anti complementary control
- 25 µl of VCM was dispensed by using a hand-held 12 channel micro pipette into wells of
rows A, C, D, E, F, and H
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- 25 µl of diluted sera were dispensed in wells of rows A, B, C and we homogenized wells
of rows C (column 1-12) of the test plate and picked up 25 µl from row C of the test plate
and delivered to the wells of row D ( column 1-12 ). This serial dilution was continued to
row H (column 1-12) from which after homogenized 25 µl was picked up and discarded
1. 25 µl of diluted antigen was added into all the wells of rows B, C, D, E, F, G,
H and wells antigen and positive and negative control wells
2. 25 µl of diluted complement was added in the wells of rows A, B, C, D, E, F,
G, H and all control wells except complement and hemolytic system
3. The plate was covered with sealer and incubated at +37oC under constant
agitation on incubator shaker for 30 minutes.
4. 25 µl hemolytic system was added to all wells including control wells
5. The plate covered with sealer and incubated at 37oC under constant agitation
on incubator shaker for 30 minutes
G. Control
- 25 µl of VCM was added into the wells of serum and antigen controls but for
complement and hemolytic system 50 µl and 75 µl respectively
- 25 µl of control sera was added into the wells of first row at a dilution rate of 1/2 up to
1/8 for negative sera and 1/2 up to 1/128 for positive sera
- 25 µl of diluted antigen was added into all wells of antigen and from row B for the
positive and negative controls
- Complement control: 25 µl of undiluted complement was added into the first well,
and in the second well 25 µl of undiluted complement and 25 µl of VCM was added
prior to homogenization. and transferred to third complement control well and 25 µl
VCM into third and fourth well, then 25 µl of the mixture was homogenized and
transferred into third and fourth well and finally 25 µl of the mixture from the fourth
well.
E. Reading: the plate was put in a refrigerator at +4oC for 1 hour to let non-hemolysed sRBC
sediment, then the result was read over view box for degree of sedimentation or hemolysis.
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Plate layout for test samples
1 2 3 4 5 6 7 8 9 10 11 12
A Ac Ac Ac Ac Ac Ac Ac Ac Ac Ac Ac Ac
B 1/2
C 1/4
D 1/8
E 1/16
F 1/32
G 1/64
H 1/128
For each set of reaction five controls must be included serum (positive and negative), Ag, C and HS.
Serum test at various two fold dilution 1:2, 1:4, 1:8, 1:16, 1:16, 1:32, 1:64, 1:128
 For serum controls first row A was used for anti complementary activity
 VCM was added to well A, C, D, E, F, G, and H
 serum was added 1:2 into well A, B and C then from C serially diluted and discarded (25 µl)
from the last well for both positive and negative controls
F. Validation
i. Positive serum control: the inhibition of hemolysis should occur up to the expected dilution.
ii. Negative serum control: should show complete hemolysis
iii. Antigen control: complete hemolysis is expected
iv. Complement control: complete hemolysis in the first two wells (pure and 1/2), partial
hemolysis in the third well (1/4) trace of hemolysis in fourth well (1/8)
v. Hemolytic system control: no hemolysis
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Annex 5: Body Condition Scoring
Poor body condition: spinous process is prominent and sharp, the transverse processes are also
sharp, the finger pass easily under the ends, and it is possible to feel between each process. The
eye muscle areas are shallow with no fat cover.
Moderate body condition: the spinous process is detected only as a small elevation, it is
smooth and rounded and individual bone can be felt only with pressure. The transverse process
is smooth and well curved, and firm pressure is required to feel over the ends. The eye muscle
area is full and has a moderate degree of the fat cover.
Good: the spinous process can just be detected with pressure as hard line between the fat
covered eyes muscles area is full, and has thick covering of the fat
Source: Alemu and Merkel (2008).
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